The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Cooper Graham K since year 2005.
The trader's CIK number is 1396943.
At the time of this reporting, Cooper Graham K is the Chief Financial Officer of Receptos, Inc. .
(stock ticker symbol RCPT).
See this page for all insider trading activities at Receptos, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2014-09-16||RCPT||Receptos, Inc.||Option Ex||50,000||5.10||254,999|
|2009-12-21||OREX||Orexigen Therapeutics, Inc.||Option Ex||100,000||.70||70,000|
|2009-12-21||OREX||Orexigen Therapeutics, Inc.||Sale||82,500||8.25||680,460|
|2009-12-21||OREX||Orexigen Therapeutics, Inc.||Sale||17,500||8.41||147,157|
|2008-08-21||OREX||Orexigen Therapeutics, Inc.||Option Ex||8,259||.70||5,781|
|2008-08-21||OREX||Orexigen Therapeutics, Inc.||Sale||8,259||12.00||99,108|
|2007-12-20||OREX||Orexigen Therapeutics, Inc.||Option Ex||4,000||.70||2,800|
|2007-12-20||OREX||Orexigen Therapeutics, Inc.||Sale||4,000||14.10||56,400|
|2007-11-20||OREX||Orexigen Therapeutics, Inc.||Sale||4,000||14.75||58,984|
|2007-11-20||OREX||Orexigen Therapeutics, Inc.||Option Ex||4,000||.70||2,800|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cooper Graham K (Chief Financial Officer of Receptos, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.